Jump to navigation Jump to search
This image is provided by the National Library of Medicine.

WikiDoc Resources for Oxeladin


Most recent articles on Oxeladin

Most cited articles on Oxeladin

Review articles on Oxeladin

Articles on Oxeladin in N Eng J Med, Lancet, BMJ


Powerpoint slides on Oxeladin

Images of Oxeladin

Photos of Oxeladin

Podcasts & MP3s on Oxeladin

Videos on Oxeladin

Evidence Based Medicine

Cochrane Collaboration on Oxeladin

Bandolier on Oxeladin

TRIP on Oxeladin

Clinical Trials

Ongoing Trials on Oxeladin at Clinical Trials.gov

Trial results on Oxeladin

Clinical Trials on Oxeladin at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Oxeladin

NICE Guidance on Oxeladin


FDA on Oxeladin

CDC on Oxeladin


Books on Oxeladin


Oxeladin in the news

Be alerted to news on Oxeladin

News trends on Oxeladin


Blogs on Oxeladin


Definitions of Oxeladin

Patient Resources / Community

Patient resources on Oxeladin

Discussion groups on Oxeladin

Patient Handouts on Oxeladin

Directions to Hospitals Treating Oxeladin

Risk calculators and risk factors for Oxeladin

Healthcare Provider Resources

Symptoms of Oxeladin

Causes & Risk Factors for Oxeladin

Diagnostic studies for Oxeladin

Treatment of Oxeladin

Continuing Medical Education (CME)

CME Programs on Oxeladin


Oxeladin en Espanol

Oxeladin en Francais


Oxeladin in the Marketplace

Patents on Oxeladin

Experimental / Informatics

List of terms related to Oxeladin

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]


Oxeladin is a cough suppressant. It is a highly potent and effective drug used to treat all types of cough of various etiologies. It is not related to opium or its derivatives, so treatment with oxeladin is free of risk of dependence or addiction. Oxeladin has none of the side effects (such as hypnosis, respiratory depression, tolerance, constipation and analgesia) which are present when common antitussives, such as codeine and its derivatives, are used. It may be used at every age, as well as in patients with heart disease, since it has a high level of safety and a great selectivity to act on the bulbar centre of cough.


Oxeladin is indicated in all types of cough. Besides its antitussive action, it helps to clear the respiratory tract, since it increases the quantity of secretion and thins bronchial secretion.


Although fetal malformations have not been reported, oxeladin should not be used during the first trimester of pregnancy. Oxeladin is contraindicated in patients with MAOI therapy.

Side effects

Rarely, some patients have reported rash, dizziness, sedation or mild digestive disturbances. These usually disappear on reducing the dosage or interrupting the treatment.


Oxeladin differs from common antitussives that cause addiction (such as etilmorphin, codeine or its derivatives) in that there is no evidence of risk of addiction or dependence.

Composition and packaging

Oxeladin is available as drops, syrup and tablets, providing easier ways of management which will be chosen depending on the age and clinical stage.


Each 1ml (33 drops) contains oxeladin citrate 20 mg. The bottle contains 20ml of solution.


Each 100ml contains oxeladin citrate 200 mg. The bottle contains 100ml of syrup.


Each tablet contains oxeladin citrate 20 mg. The box contains 20 tablets in blister packs


  • Children 2-5yrs: 2.5ml-5ml (17 drops) every 4-6 hours
  • Children 6-12 yrs: 10ml (33 drops), or 1 tablet, every 4-6 hours
  • Children 12 yrs and over and adults: 15ml (50 drops), or 2 tablets, every 4-6 hours

Restrictions in use and availability

The Drug and Medical Technology Agency of Armenia rejected the registration of oxeladin in July 2000 since studies in[[Germany have shown potential carcinogenicity of the drug.